Upcoming Events
Search Result For "Bispecific".
- Event Type
- Event Category
- Event Country
- Event Date
Event Type
Categories
Country
City
Date
Bispecifics and T-cell engagers are redefining the future of solid tumor treatment. With the landmark approvals of tarlatamab and ivonescimab, t...
The 5th World ADC Summit South Korea (9-11 June 2026 | Seoul) is Asia's premier meeting dedicated to accelerating next-generation antibody drug ...
The bispecific and multispecific antibody field is advancing rapidly, fuelled by strong clinical readouts, growing biopharma investment, and inc...
The TCE pipeline is ever-growing and there are multiple different formats, engagers and costimulatory being studied in over 90 trials, with over a ...
Be at the forefront of the Bispecific space as it goes head to head with cell therapy to transform oncology. Among numerous innovations in cancer i...
Prioritizing Back Translation from Bedside to Bench and Novel Targets With a whopping 7 approvals in the last two years, the field is alive with p...
As of 2023, more than 10 bispecific antibodies have been successfully approved by the FDA, and more than 100 are currently in clinical trials, high...
Join us at the inaugural Novel Targeting Moiety and Payload Conjugate Summit Europe, the premier event for Europe's burgeoning novel drug conjugate...
Your End-to-End Forum to Maximise the Therapeutic Index and Accelerate Your Journey from Concept to Approved Therapy Antibody-drug conjugates re...
Celebrating a Decade of Uniting the NK Cell Therapy Community! As the NK community remains determined as ever to prove the advantages of NK cell...
Welcome to the 4th Novel Conjugates Summit! We are witnessing a surging 83% growth of novel drug conjugates, with major collaborations between N...
The landscape of biologics discovery is rapidly evolving, driven by breakthroughs in AI, an influx of high-quality datasets, and regulatory momentu...
Loading More...
